The limitless endophytes: their role as antifungal agents against top priority pathogens

Ashaimaa Y. Moussa

DOI: https://doi.org/10.1186/s12934-024-02411-3

IF: 6.352

2024-06-02

Microbial Cell Factories

Abstract:Multi resistant fungi are on the rise, and our arsenal compounds are limited to few choices in the market such as polyenes, pyrimidine analogs, azoles, allylamines, and echinocandins. Although each of these drugs featured a unique mechanism, antifungal resistant strains did emerge and continued to arise against them worldwide. Moreover, the genetic variation between fungi and their host humans is small, which leads to significant challenges in new antifungal drug discovery. Endophytes are still an underexplored source of bioactive secondary metabolites. Many studies were conducted to isolate and screen endophytic pure compounds with efficacy against resistant yeasts and fungi; especially, Candida albicans, C. auris, Cryptococcus neoformans and Aspergillus fumigatus, which encouraged writing this review to critically analyze the chemical nature, potency, and fungal source of the isolated endophytic compounds as well as their novelty features and SAR when possible. Herein, we report a comprehensive list of around 320 assayed antifungal compounds against Candida albicans, C. auris, Cryptococcus neoformans and Aspergillus fumigatus in the period 1980–2024, the majority of which were isolated from fungi of orders Eurotiales and Hypocreales associated with terrestrial plants, probably due to the ease of laboratory cultivation of these strains. 46% of the reviewed compounds were active against C. albicans, 23% against C. neoformans, 29% against A. fumigatus and only 2% against C. auris . Coculturing was proved to be an effective technique to induce cryptic metabolites absent in other axenic cultures or host extract cultures, with Irperide as the most promising compounds MIC value 1 μg/mL. C. auris was susceptible to only persephacin and rubiginosin C. The latter showed potent inhibition against this recalcitrant strain in a non-fungicide way, which unveils the potential of fungal biofilm inhibition. Further development of culturing techniques and activation of silent metabolic pathways would be favorable to inspire the search for novel bioactive antifungals.

biotechnology & applied microbiology

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are the effectiveness and drug - resistance of antifungal drugs. Specifically, with the increase of multi - drug - resistant fungi, the existing antifungal drug options are limited, and the effects of these drugs on resistant fungi are gradually weakening. In addition, because the genetic difference between fungi and human hosts is small, this brings significant challenges to the discovery of new antifungal drugs. Therefore, this article aims to explore the potential of endophytes as antifungal agents against priority pathogens such as *Candida auris*, *Aspergillus fumigatus* and *Cryptococcus neoformans*.

The paper analyzed the chemical properties, potencies, sources and novel characteristics of about 320 tested antifungal compounds from 1980 to 2024, especially those isolated from fungi of the order Eurotiales and Sphaeriales, through a review. In addition, the paper also discussed the effectiveness of co - culture techniques in inducing cryptic metabolites and proposed the importance of further developing culture techniques and activating silent metabolic pathways to promote the discovery of new bioactive antifungal drugs.

In conclusion, the goal of this paper is to provide new ideas and directions for solving the current problems of antifungal drug resistance and limitation by systematically evaluating the antifungal compounds produced by endophytes.